Summary
An insulin-related growth-promoting substance was detected in the serum of a patient with Hodgkin's disease who suffered from severe hypoglycaemia, as well as in the supernatant of homogenized spleen tissue of the same patient. Low concentrations of this substance enhanced DNA synthesis of short-term-cultured spleen tumour cells obtained from the same patient, while the addition of anti-insulin antiserum interfered with that effect. Moreover, the preincubation of this insulin-related substance with the anti-insulin antiserum abrogated its stimulatory effect on tumour cell proliferation. Both insulin and the insulin-related substance bound to patients splenocytes to a similar extent. The data suggest that the insulin-related substance, found in this particular case of Hodgkin's disease, plays a role in tumour progression by an autocrine mechanism.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- SICRI:
-
substance immunologically cross-reactive with insulin
- PDGF:
-
platelet-derived growth factor
- EGF:
-
epidermal growth factor
- FGF:
-
fibroblast growth factor
- ECGF:
-
endothelial cell growth factor
- IGF:
-
insulin-like growth factor
References
Bajzer Z, Pavelić K, Vuk-Pavlović S (1984) Growth self-incitement in murine melanoma B-16: a phenomenological model. Science 225:930–932
Čabrijan T, Pačarizi H, Levanat S, Vrbanec D, Pavelić J, Milković D, Spaventi R, Končar M, Baltić V, Spaventi Š, Pavelić K (1988) Autocrine tumor growth regulation by the insulin growth factor I (IGF I) and the epidermal growth factor (EGF). In: Bresciani F et al. (eds) Progress in cancer research and therapy, vol 35. Hormones and Cancer 3. Raven, New York, pp 227–230
Fraizier WA, Angeletti RH, Bradshaw AR (1972) Nerve growth factor and insulin. Structural similarities indicate an evolutionary relationship reflected by physiological action. Science 176:482–488
Gammeltoft S, Gliemann J (1973) Binding and degradation of125I-labeled insulin by isolated non-fat cells. Biochim Biophys Acta 320:16–32
Ginsberg BB, Kahn RC, Roth J, Megyesi K, Baumann G (1979) Identification and high yield purification of insulin-like growth factors (nonsuppressible insulin-like activities and somatomedins) from human plasma by use of endogenous binding proteins. J Clin Endocrinol Metab 48:42–49
Hyvarinen A, Nikkila BY (1962) Specific determination of blood glucose witho-toluidine. Clin Chim Acta 7:140–143
Levanat S, Pavelić K (1989) Isolation and purification of a substance immunologically cross-reactive with insulin (SICRI) from tumor tissue. Int J Biochem 21:509–515
Levanat S, Pavelić K (1990) Isolation and purification of substance immunologically cross reactive with insulin from murine myeloid leukemia. Biol Chem Hoppe-Seyler 371:250–254
Morgan CR, Lazarow (1963) Immunoassay of insulin. Two antibody systems. Plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes 12:115–121
Pavelić K (1979) Aplastic carcinoma in diabetic mice: hyperglycemia suppresses proliferation rate and insulin synthesis by tumor cells. J Natl Cancer Inst 62:139–141
Pavelić K, Popović M (1981) Insulin and glucagon secretion by renal adenocarcinoma. Cancer 48:98–100
Pavelić K, Vuk-Pavlović S (1983) C-peptide does not parallel increase of serum levels of substances immunologically cross-reactive with insulin in non-Hodgkin's lymphoma patients. Blood 61:925–928
Pavelić K, Pekić B, Slijepčević M, Popović M (1980) Insulin levels in Hodgkin's disease. Br J Haematol 46:133–135
Pavelić K, Odavić M, Pekić B, Hršak I, Vuk-Pavlović S (1982a) Correlation of substance(s) immunologically cross-reactive with insulin, glucose and growth hormone in Hodgkin's lymphoma patients. Cancer Lett 17:81–86
Pavelić K, Bolanča M, Veček N, Pavelić J, Marotti T, Vuk-Pavlović S (1982b) Carcinoma of the cervix and corpus uteri in humans: stage-dependent blood levels of substance(s) immunologically cross-reactive with insulin. J Natl Cancer Inst 68:891–894
Pavelić K, Vrbanec D, Marušić S, Levanat S, Čabrijan T (1986) Autocrine growth regulation by somatomedin C: an in vitro model. J Endocrinol 109:233–238
Pavelić LJ, Pavelić K, Vuk-Pavlović S (1984) Human mammary and bronchial carcinomas. In vivo and in vitro secretion of substances immunologically cross-reactive with insulin. Cancer 53:2467–2471
Shields R (1977) Growth factors for tumors. Nature 267:308
Sporn MB, Todaro GL (1980) Autocrine secretion and malignant transformation of cells. N Engl J Med 303:878–880
Vuk-Pavlović S, Opara EC, Levanat S, Vrbanec D, Pavelić K (1986a) Autocrine tumor growth regulation and tumor associated hypoglycemia in murine melanoma B 16 in vivo. Cancer Res 46:2208–2213
Vuk-Pavlović Z, Pavelić K, Vuk-Pavlović S (1986b) Modulation of in vitro growth of murine leukemia by an autologous substance immunochemically cross-reactive with insulin and antiinsulin serum. Blood 67:1031–1035
Županović Ž, Gabrilovac J, Brayer D, Ročić B, Pavelić K (1983) Insulin receptors on cells of mouse myeloid leukemia. Period Biol 85:97–98
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Čabrijan, T., Levanat, S., Pekić, B. et al. The role of insulin-related substance in Hodgkin's disease. J Cancer Res Clin Oncol 117, 615–619 (1991). https://doi.org/10.1007/BF01613298
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01613298